Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications lack effect raloxifene coronary atherosclerosis postmenopausal monkeys authors response
Benefit-Risk Assessment Do your product’s benefits outweigh its potential risks? More importantly, do you have the right data to credibly demonstrate this to regulators, payers, physicians, and patients? You can rely on our experienced team to help you …
Navigating market access pathways across European Union markets in 2025 and beyond What do the joint clinical assessments (JCA) in Europe mean for your pharma or medtech company? The parallel paths of the joint clinical assessment process and the …
Knowledgebase - ICER Evaluations Image Image Image Knowledgebase KB Image Image KB …
… 6 - Wednesday, February 7, 2024 Meeting website In response to a US Congressional request, an ad hoc committee …
Benefit-Risk Preferences Benefit-risk preference studies are a specific application of stated-preference methods and are used to determine how your patients and other decision-makers perceive the benefits of your treatment features and their tolerance for …
SIGMA Stakeholder Announcement Share on: January 15, 2021 Launch of the SIGMA Consortium heralds a new era of collaboration to better understand safety and effectiveness of medical interventions. Research institutions compete for resources to carry out …
Canadian Association for Population Therapeutics Conference 2022 Share on: Monday, October 17 - Tuesday, October 18, 2022 Conference Website Research coauthored by RTI Health Solutions researchers will be presented at the 2022 Canadian Association for …
RTI Health Solutions Joins MDIC Collaborative Share on: October 18, 2016 RTI Health Solutions Joins Collaborative to Include Patient Risk Preference in Clinical Trials RESEARCH TRIANGLE PARK, NC – (October 18, 2016) – RTI Health Solutions , a business …
… and Biological Products Share on: October 10, 2023 In response to the 21st Century Cures Act, which aims to …
HTA Processes for Medical Technologies Across the World – Are All Hurdles the Same? Liesl Gildea, MSc Associate Director, Market Access and Outcomes Strategy RTI Health Solutions HTA processes for medical technologies across the world – are all hurdles …